Santanu Maji

Mcl-1 is an important therapeutic target for oral squamous cell carcinomas

Santanu Maji, Sabindra K. Samal, Laxmipriya Pattanaik et al. · Oncotarget · 2015 · 59 citations · Full text

Veterinary Medicine, Oncology, Oral Pathology +13

Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma

Y. Rajesh, Angana Biswas, Utkarsh Kumar et al. · Proceedings of the National Academy of Sciences · 2020 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma

Santanu Maji, Omprakash Shriwas, Sabindra K. Samal et al. · Carcinogenesis · 2018 · 47 citations

Medicine, Cancer Biology, Oncology +14

Good's buffer derived highly emissive carbon quantum dots: excellent biocompatible anticancer drug carrier

Aneeya K. Samantara, Santanu Maji, Arnab Ghosh et al. · Journal of Materials Chemistry B · 2016 · 39 citations

Natural Sciences, Chemistry, Materials Science +14

Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β

Anjan K. Pradhan, Santanu Maji, Praveen Bhoopathi et al. · Proceedings of the National Academy of Sciences · 2021 · 30 citations · Full text

Medicine, Oncology, Pharmacology +15